Product Information

PIOGLITAZONE-GLIMEPIRIDE 30-2 is a generic product labeled by Prasco Laboratories, priced at $10.7803 per EA under NDC 66993082130. Its NADAC has been published 177 times since Oct 7, 2015.

PIOGLITAZONE-GLIMEPIRIDE 30-2

pioglitazone and glimepiride

$10.7803per EA

Strength

2; 30 mg/1; mg/1

Manufacturer

Prasco Laboratories

NDC

66993082130

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

GLIMEPIRIDE; PIOGLITAZONE HYDROCHLORIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021925

On Market Since

8/4/2015

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist

Peroxisome Proliferator Receptor gamma Agonist

Peroxisome Proliferator-activated Receptor alpha Agonists

Peroxisome Proliferator-activated Receptor gamma Agonists

Sulfonylurea Compounds

Sulfonylurea

Thiazolidinedione

Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE-GLIMEPIRIDE 30-2 has been published 177 times since Oct 7, 2015, and over the history we have for it it has risen 18.6%. The table below summarizes its recorded NADAC range and movement.

Current price	$10.7803 per EA
All-time high	$11.3091 (Jan 10, 2018)
All-time low	$7.2022 (Aug 21, 2024)
52-week high	$10.8009
52-week low	$10.2320
Median price	$10.5207
Average price	$10.0490
Largest weekly change	-36.3% (Aug 21, 2024)
Weeks tracked	177
Tracking since	Oct 7, 2015

Price History

0.0%

-0.2%

+2.5%

+5.4%

-4.7%

All

+18.6%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

DUETACT 30-2 MG TABLET

Brand

64764030230•Takeda Pharmaceuticals America, Inc.

$19.1240

+77% more

Frequently asked questions

What is the NADAC price of PIOGLITAZONE-GLIMEPIRIDE 30-2?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-GLIMEPIRIDE 30-2, manufactured by Prasco Laboratories, is $10.7803 per EA (NDC 66993082130), effective Jun 24, 2026.

How has the price of PIOGLITAZONE-GLIMEPIRIDE 30-2 changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE-GLIMEPIRIDE 30-2 has risen 18.6%. It has been tracked across 177 weekly CMS publications since Oct 7, 2015.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-GLIMEPIRIDE 30-2?

Since Oct 7, 2015, the NADAC for PIOGLITAZONE-GLIMEPIRIDE 30-2 has ranged from a low of $7.2022 (Aug 21, 2024) to a high of $11.3091 (Jan 10, 2018), with a median of $10.5207 per EA.

Are there cheaper alternatives to PIOGLITAZONE-GLIMEPIRIDE 30-2?

1 NADAC-published product shares the same active ingredient, strength, and dosage form as PIOGLITAZONE-GLIMEPIRIDE 30-2, but none are currently priced below it.